Found 5 robert-micheletti trials
A listing of robert-micheletti medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This study aims to find out if a new investigational drug, vilobelimab (also called IFX-1) is safe and effective in treating subjects 18 and older diagnosed Ulcerative Pyoderma Gangrenosum. Procedures include blood and urine tests, a physical examination, vital signs, body weight and height, an electrocardiogram (ECG), and full assessment …
The purpose of this study is to determine if the research drug, sonelokimab, is effective in reducing the signs and symptoms of HS in people with moderate to severe disease, compared to placebo. Procedures include Vital signs, Physical Exam, Medical History, Blood and Urine tests, EKG and electronic questionnaires.
The purpose of this study is to evaluate different treatment options for patients with skin vasculitis (also named cutaneous vasculitis). Patients with isolated cutaneous small vessel vasculitis, medium-sized vessel vasculitis (polyarteritis nodosa), or IgA vasculitis (Henoch-Schönlein purpura) can join this study. The frequently used treatments for skin vasculitis are colchicine, …
This study employs a multi-center approach to evaluate cutaneous vasculitis across several forms of idiopathic vasculitis. Patients with cutaneous manifestations of vasculitis will be evaluated by teams of primary vasculitis care providers and Dermatologists in order to facilitate optimal selection of patients and sampling of lesions. A punch skin biopsy …
The purpose of this study is to identify the clinical and biological characteristics of HS. Subject over the age of 18 diagnosed with HS will have one initial study visit and then be seen every 6 months during their standard routine clinic visit. First visit will consist of completing a …
